- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03233984
Effect of an Environmental Health Education Program on Pregnant Women in Order to Reduce Endocrine Disruptor Exposition
Effect of an Environmental Health Education Program on Pregnant Women in Order to Reduce Endocrine Disruptor Exposition : Controled Randomized Trial on Primary Prevention
Endocrine disruptors are known as a cancer cause. On pregnant women, it can induce major foetal pathology and impact growth.
Among those molecules, bisphenol-A (BPA) is a plasticizer that can be found on cans and water.
Through a prevention program, the investigators tried to warned pregnant women on endocrine disruptors exposition risks. The goal here is to assess the effectiveness of this program on their fresh products consumption.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Poitiers, France, 86000
- Centre Hospitalier Universitaire de Poitiers
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients over 18
- Patients living in Poitiers or city around (near the immersive environment)
- Patients on pregnancy and who declared their pregnancy to the authority
- Patients who planned to give birth in Poitiers's hospital, Châtellerault's hospital or Clinique Fief de Grimoire, in Poitiers.
- Patients giving her agreement
Exclusion Criteria:
- Patients planning to move during the study
- Patients under legal protection
- Patients expecting twins
- Patients unable to speak french
- Patients willing to give birth in another hospital than those mentionned before
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Leaflet only
Women will only receive a leaflet about endocrine disruptor at home.
|
|
ACTIVE_COMPARATOR: non immersive program
In addition of the leaflet, women will sit in the sensibilisation program that will take place in a neutral environment
|
The aim of this program is to spread the awarness about endocrine disruptors through workshops and presentation.
|
EXPERIMENTAL: immersive program
In addition of the leaflet, women will si in the sensibilisation program that will take place in an immersive environment
|
The aim of this program is to spread the awarness about endocrine disruptors through workshops and presentation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
program effectivness
Time Frame: During the pregnancy (second and third trimester)
|
Assessing the Effectiveness of the Prevention Program "My Home, My Health Environment" (consists of a series of workshop in the second and third trimesters of pregnancy) in an immersive environment or not, to evaluate the consumption of fresh products according to exposure endocrine disruptors (cans or industrial products).
|
During the pregnancy (second and third trimester)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
psychosocial aspects
Time Frame: During the pregnancy (second and third trimester)
|
Assess if the program impact any psychosocial aspects, this outcome will be determine with a psychosocial questionary (to do before and after the intervention for compare the results)
|
During the pregnancy (second and third trimester)
|
Urine concentration
Time Frame: During the pregnancy (second and third trimester)
|
Assess if the program has an impact on the urinary endocrine disruptors's concentrations, this outcome will be determine with samples of urine (to do before and after the intervention for comparate the results)
|
During the pregnancy (second and third trimester)
|
Milk concentration
Time Frame: After the birth of the child (first year)
|
Assess the milk endocrine disruptors's concentration difference between women exposed and unexposed to the program
|
After the birth of the child (first year)
|
foetal growth
Time Frame: After the birth of the child (first year)
|
Study the relation between endocrine disruptors expositions and foetal growth by merging PREVED and EDDS (a previous trial) datas.
|
After the birth of the child (first year)
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PREVED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Hopital Antoine BeclereUnknown
-
Turku University HospitalUniversity of TurkuCompleted
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium